1. Home
  2. CMPX vs SHMD Comparison

CMPX vs SHMD Comparison

Compare CMPX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$5.34

Market Cap

927.5M

Sector

Health Care

ML Signal

N/A

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

N/A

Current Price

$6.66

Market Cap

323.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CMPX
SHMD
Founded
2014
1864
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
927.5M
323.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPX
SHMD
Price
$5.34
$6.66
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$14.43
N/A
AVG Volume (30 Days)
1.8M
799.0K
Earning Date
03-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$677.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$2.00
52 Week High
$6.88
$10.65

Technical Indicators

Market Signals
Indicator
CMPX
SHMD
Relative Strength Index (RSI) 43.75 46.42
Support Level $4.86 $2.36
Resistance Level $5.86 $6.70
Average True Range (ATR) 0.29 0.78
MACD -0.02 0.02
Stochastic Oscillator 46.00 29.65

Price Performance

Historical Comparison
CMPX
SHMD

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: